Bromelain is a mixture of proteolytic enzymes and other compounds (phosphatases, glucosidases, peroxidases, cellulases) extracted from pineapple stems and fruit. It exhibits anti-inflammatory, fibrinolytic, antiedematous, and antithrombotic properties, and is notably absorbed systemically in functionally intact form without losing proteolytic activity. Bromelain is used both topically for wound healing and orally for digestive support, sinusitis, inflammation, and post-surgical recovery.

Overview

Bromelain refers to a complex mixture of cysteine proteases and other bioactive compounds derived from the pineapple plant (Ananas comosus). First isolated in the late 19th century, bromelain has been the subject of extensive research for its therapeutic potential, particularly in the areas of inflammation, wound healing, and digestive health. It is available as a dietary supplement and has been approved in some European countries as an adjunctive therapy for inflammatory conditions.

The enzymatic activity of bromelain enables it to break down proteins into smaller peptides and amino acids, which underlies its traditional use as a digestive aid. Beyond digestion, bromelain modulates several pathways involved in inflammation, including the reduction of prostaglandins, thromboxane A2, and bradykinin. It has also demonstrated the ability to reduce platelet aggregation and exert mild fibrinolytic effects, which has prompted investigation into cardiovascular applications.

Clinical studies have examined bromelain for conditions such as osteoarthritis, sinusitis, surgical recovery, and soft tissue injuries. While results have been mixed, several trials suggest meaningful reductions in swelling, pain, and healing time when bromelain is used as a complementary treatment. The German Commission E has approved bromelain for the treatment of swelling and inflammation following surgery or trauma, particularly of the nasal and paranasal sinuses.

Mechanism of Action

Cysteine Protease Complex

Bromelain is a mixture of cysteine endopeptidases extracted from pineapple stems (Ananas comosus), with stem bromelain (EC 3.4.22.32) as the principal proteolytic component. It cleaves peptide bonds preferentially at the carboxyl side of lysine, alanine, tyrosine, and glycine residues. The active site contains a catalytic triad of Cys-26, His-158, and Asn-175 with a thiol-imidazolium ion pair mechanism analogous to papain. Bromelain retains proteolytic activity across a broad pH range (3.0-8.0), allowing function in both gastric and intestinal environments (PMID: 22426836).

Anti-Inflammatory — COX/LOX & Kinin System

Bromelain exerts anti-inflammatory effects through: (1) modulation of prostaglandin synthesis by shifting the PGE1/thromboxane ratio toward anti-inflammatory prostaglandins via selective inhibition of thromboxane A2 generation, (2) reduction of bradykinin levels at sites of tissue injury by proteolytic degradation of high-molecular-weight kininogen and kallikrein, and (3) inhibition of the arachidonic acid cascade through modulation of COX-2 and 5-LOX expression. These mechanisms reduce edema, pain, and vascular permeability at inflammatory sites (PMID: 12127240).

Immune Modulation & CD44 Processing

Bromelain selectively removes CD44 surface molecules from T cells and macrophages through proteolytic cleavage. CD44 is a glycoprotein receptor for hyaluronic acid that mediates leukocyte adhesion and extravasation. By reducing CD44 density, bromelain decreases T-cell adhesion to endothelial cells and extravasation into inflamed tissues, attenuating leukocyte-mediated tissue damage while paradoxically enhancing T-cell activation through co-stimulatory signal modification (PMID: 15056839).

Fibrinolytic & Anti-Thrombotic Activity

Bromelain exhibits fibrinolytic activity by degrading fibrin directly and by activating plasminogen conversion to plasmin. It also reduces platelet aggregation by lowering thromboxane A2 production and inhibiting platelet ADP-receptor signaling, reducing thrombotic risk (PMID: 18061937).

Reconstitution Calculator

Research

Safety Profile

Common Side Effects

• Gastrointestinal symptoms are the most common side effects, including diarrhea, nausea, stomach cramps, and increased bowel movements, particularly at doses above 500 mg daily
• Allergic reactions in individuals with sensitivities to pineapple or other bromeliad-family plants, manifesting as skin rash, itching, or mild respiratory symptoms
• Menstrual irregularities including heavier menstrual flow have been reported

Serious Adverse Effects

• Anaphylactic reactions have been documented, particularly in individuals with pineapple allergy or latex allergy (cross-reactivity)
• Increased bleeding risk due to fibrinolytic and antiplatelet activity; this is clinically significant in surgical or trauma contexts
• Rare cases of angioedema (swelling of deeper skin layers) have been reported
• Very high doses in animal studies have been associated with increased heart rate and GI mucosal changes

Contraindications

• Contraindicated in individuals with known allergy to pineapple, papain, or latex due to cross-reactivity risk
• Should be avoided or used with extreme caution in individuals with bleeding disorders (hemophilia, von Willebrand disease) due to anticoagulant and fibrinolytic effects
• Discontinue at least 2 weeks before scheduled surgery to minimize bleeding risk
• Not recommended in individuals with active peptic ulcers, as bromelain may exacerbate mucosal irritation

Drug Interactions

• Significant interaction with anticoagulants (warfarin, heparin, enoxaparin) and antiplatelet agents (aspirin, clopidogrel, ticagrelor) due to additive bleeding risk; INR monitoring is essential with warfarin co-administration
• May increase absorption and plasma levels of antibiotics, particularly amoxicillin and tetracycline, as demonstrated in clinical studies
• Potential interaction with ACE inhibitors, as bromelain may have mild antihypertensive properties
• May potentiate the sedative effects of certain medications due to mild central nervous system depressant properties observed at high doses
• Can increase the bioavailability of chemotherapy agents (5-fluorouracil, vincristine); oncologist consultation is mandatory

Special Populations

• Limited safety data during pregnancy; some traditional medicine sources suggest it may stimulate uterine contractions, and avoidance during pregnancy is generally recommended
• Breastfeeding safety has not been established
• Pediatric use has been studied for sinusitis with acceptable safety profiles at age-appropriate doses
• Elderly patients on anticoagulant therapy require close monitoring

Pharmacokinetic Profile